Page last updated: 2024-10-25

deferiprone and Kidney Failure, Chronic

deferiprone has been researched along with Kidney Failure, Chronic in 2 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kontoghiorghes, GJ1
Barr, J1
Baillod, RA1
Canteros-Piccotto, MA1
Fernández-Martín, JL1
Cannata-Ortiz, MJ1
Cannata-Andía, JB1

Other Studies

2 other studies available for deferiprone and Kidney Failure, Chronic

ArticleYear
Studies of aluminium mobilization in renal dialysis patients using the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:4

    Topics: Adult; Aged; Aluminum; Chromatography, High Pressure Liquid; Deferiprone; Female; Humans; Iron; Iron

1994
Effectiveness of deferiprone (L1) releasing the aluminum bound to plasma proteins in chronic renal failure.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1996, Volume: 11, Issue:7

    Topics: Aluminum; Blood Proteins; Chelating Agents; Deferiprone; Humans; In Vitro Techniques; Kidney Failure

1996